Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · IEX Real-Time Price · USD
8.42
+0.22 (2.68%)
At close: May 1, 2024, 4:00 PM
8.23
-0.19 (-2.26%)
After-hours: May 1, 2024, 6:57 PM EDT
MRVI Revenue
In the year 2023, Maravai LifeSciences Holdings had annual revenue of $288.95M, a decrease of -67.28%. Revenue in the quarter ending December 31, 2023 was $74.14M, a -63.78% decrease year-over-year.
Revenue (ttm)
$288.95M
Revenue Growth
-67.28%
P/S Ratio
3.86
Revenue / Employee
$444,531
Employees
650
Market Cap
1.11B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 288.95M | -594.06M | -67.28% |
Dec 31, 2022 | 883.00M | 83.76M | 10.48% |
Dec 31, 2021 | 799.24M | 515.14M | 181.33% |
Dec 31, 2020 | 284.10M | 140.96M | 98.48% |
Dec 31, 2019 | 143.14M | 19.31M | 15.59% |
Dec 31, 2018 | 123.83M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AtriCure | 399.25M |
Innoviva | 310.46M |
MannKind | 198.96M |
Prothena Corporation | 91.37M |
Vir Biotechnology | 86.18M |
Immatics | 60.00M |
Arcutis Biotherapeutics | 59.61M |
AbCellera Biologics | 38.03M |
MRVI News
- 2 days ago - TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology - Business Wire
- 14 days ago - TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production - Business Wire
- 21 days ago - Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024 - GlobeNewsWire
- 7 weeks ago - Maravai LifeSciences Announces March 2024 Investor Conference Schedule - GlobeNewsWire
- 2 months ago - Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 3 months ago - Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024 - GlobeNewsWire
- 6 months ago - Maravai LifeSciences Announces November 2023 Investor Conference Schedule - GlobeNewsWire
- 7 months ago - Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023 - GlobeNewsWire